Loading page content…
Loading page content…
| Source: | Find a Tender Service (FTS) |
| Buyer: | CARDIFF UNIVERSITY |
| Main Category: | Goods |
| Procurement Method: | Below threshold - without competition |
| Tender Status: | Complete |
| Estimated Value (ex. VAT): | Not specified |
| Release Date: | 19 January 2026 |
| Application Deadline: | — |
| Procurement ID (OCID): | ocds-h6vhtk-060896 |
| Notice Reference: | 004306-2026 |
View Original Notice
Access the full notice on the official portal
T1D-Plus trial is a randomised, adaptive, open label, parallel group, multi-centre Platform trial in adults with newly diagnosed type 1 diabetes). The T1D Plus trial, funded by JDRF, sponsored by CU, started on 30th September 2022, led by Colin Dayan. Since that time, additional arms of the trial have been funded by separate grants from the Helmsley Charitable Trust and JDRF Australia. Funding was agreed in Dec 2023. An endpoint in the trial is the recording of glucose levels by a continuous glucose monitoring device. These devices are marketed by different companies with different specifications.
Published contracts in the last 12 months
36
total contracts
£19.8m
total value
£2,824,370
average contract size
Typical categories
Pipeline status
Not addedContract imported automatically · AI writes the response
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →